Merit Medical Systems, Inc.

MMSI Healthcare Medical Instruments & Supplies

Merit Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 9.51%, EPS grew 18.2%, free cash flow fell 25.7% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

89.20 0.37 −0.41%
Market cap
$5.4B
P/E
36.4×
Fwd P/E
23.4×
Dividend yield
—
F-score
7/9
Altman Z
4.42
Beneish M
−2.70
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
28.30 29.33 40.62 41.41

+8 more quarters

P/S ratio
2.62 2.66 3.44 3.34
P/FCF ratio
20.72 18.87 24.53 24.19
P/Operating CF
59.73 100.83 52.93 65.76
P/B ratio
2.46 2.52 3.29 3.22
EV/Sales
2.81 2.82 3.63 3.57
EV/EBITDA
12.92 13.23 16.94 17.27
EV/FCF
22.17 20.02 25.90 25.88
Current Ratio
4.20 5.08 4.34 4.28
Net Debt/EBITDA
3.00 3.13 3.20 4.35
Debt/Equity
0.44 0.45 0.46 0.48
Earnings Yield
3.53% 3.41% 2.46% 2.41%
Free Cash Flow Yield
4.83% 5.30% 4.08% 4.13%
Free Cash Flow per Share
0.86 0.40 1.24 0.87
Book value per Share
28.15 27.34 26.78 25.82
Free Cash Flow
51.09 23.92 73.20 51.56
EV/EBIT
22.00 23.17 29.80 31.57
Other line items

Show all line items

Columns are period end dates